Company Information

Company Infant Bacterial Therapeutics AB
ibtherapeutics.com
Type:
SME
Country:
Sweden
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Publicly Listed
Global Compact Status:
Active
Participant Since
09 May 2022
Letter of Commitment
Next Communication on Progress (COP) due on:
31 July 2025

Financial Information


Communication On Progress

Published On Title Level/Status
04-Jul-2024 2024 Communication on Progress Submitted
20-Dec-2023 2023 Communication on Progress Submitted

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.